Related Experiment Video
Updated: Feb 16, 2026
06:56
Micro/Nano-scale Strain Distribution Measurement from Sampling Moiré Fringes
Published on: May 23, 2017
12.7K
Nano-Scale Gene Delivery Systems: Current Technology, Obstacles, and Future Directions.
Antonio Garcia-Guerra1, Thomas L Dunwell2, Sonia Trigueros1,2
1Clarendon Laboratory, Department of Physics, University of Oxford, OX1 3PU, United Kingdom.
Current Medicinal Chemistry
|January 9, 2018
Summary
Nanomedicine offers exciting potential for gene delivery, but challenges remain in creating efficient and safe systems for genetic material transport into cells. Further research into nanostructures and their biological interactions is crucial for advancing this field.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Molecular Biology
Background:
- Nanomedicine applications, particularly nanogene delivery, aim to address unmet medical needs by facilitating genetic material transport into cells.
- Effective gene delivery requires overcoming biological barriers to ensure genetic material reaches the cell nucleus for therapeutic function.
- Current nanogene delivery systems leverage nanoscale properties for improved cellular uptake and targeted delivery.
Purpose of the Study:
- To review current nanogene delivery systems used in clinical and biomedical research.
- To discuss the advantages and disadvantages of existing nanodelivery vectors.
- To identify barriers in nano-scale interactions with biological materials for efficient and non-toxic gene delivery.
Main Methods:
- Systematic literature search of bibliographic databases.
- Analysis of nanostructure synthesis and characterization techniques.
- Review of in vitro and in vivo nucleic acid delivery challenges.
Main Results:
- Despite advances in nanostructure synthesis and characterization, significant barriers persist in achieving highly efficient and non-toxic gene delivery systems.
- Existing nanodelivery vectors show promise but face limitations in overcoming biological hurdles.
- Understanding nano-scale interactions with biological systems is critical for future development.
Conclusions:
- Nanogene delivery is a rapidly evolving field with immense therapeutic potential.
- Overcoming challenges in efficiency and toxicity requires further research into nanostructure design and biological interactions.
- Multidisciplinary approaches are essential for developing targeted, nanotechnology-based gene delivery strategies.
Related Concept Videos
01:18Transdermal Drug Delivery Systems
23
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
23
01:23Ophthalmic Drug Delivery Systems
22
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
22
01:21Intrauterine Drug Delivery Systems
20
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
20
01:27Drug Delivery Systems: Different Types
16
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
16
01:26Oral Drug Delivery Systems: Continuous-Release Systems
20
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
20
01:11Oral Drug Delivery Systems: Delayed-Release Systems
24
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
24